spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  MPM Capital 

 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2021
Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 24 Feb 2021
Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2021
Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Nov 2020
Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Nov 2019
Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Sep 2018
Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Apr 2018
Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Mar 2018
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Biopharmaceuticals Oncology Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Jan 2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2015
Atopix Therapeutics Appoints Dr Andrew Zambanini as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2015
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 7 Apr 2015
True North Therapeutics Announces $35 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Feb 2015
Chiasma Announces Completion of $70 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 May 2014
Proteon Therapeutics Announces $45 Million of Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Feb 2014
CoStim Pharmaceuticals, Inc. Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2013
Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Sep 2013
$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Aug 2013
Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Mar 2013
Theraclone Sciences Secures $14 Million in Additional Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Jul 2012
NovImmune Strengthens Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
Devices
 HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 7 Jun 2012
Astute Medical Completes $40.4 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 5 Apr 2012
Syndax Pharmaceuticals Appoints Arthur M. Pappas to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Dec 2011
Theraclone Sciences Announces Appointment of Clifford Stocks as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
Valeritas Announces $150 Million Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 14 Jul 2011
Verastem Raises $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 May 2011
Verastem, Inc. Appoints Robert Forrester as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Mar 2011
Valeritas Receives FDA 510(k) Clearance for the V-Go Disposable Insulin Delivery Device for Use with NovoLog(R)
Devices Drug Delivery FDA
 HSMN NewsFeed - 7 Jan 2011
23andMe Announces Additional Investment in Series C Financing; Dr. Ashley Ledbetter Dombkowski of MPM Capital Joins 23andMe's Board of Directors
Personalized Medicine Venture Capital Personnel
 HSMN NewsFeed - 7 Jan 2011
Aratana Therapeutics Announces $20 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Dec 2010
Accelerator Corporation Finances Eleventh Startup with Acylin Therapeutics, Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Nov 2010
Verastem Secures $16 Million in Series A Financing for Novel Cancer Stem Cell Drugs
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
iPierian Announces Second Close of $28 Million Series B Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2010
EndoGastric Solutions Completes $30 Million Financing Round
Devices Surgery Venture Capital
 HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2010
Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2010
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 3 Mar 2010
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jan 2010
Alnara Pharmaceuticals Secures $35 Million in Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Dec 2009
Epizyme Closes $40M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Nov 2009
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 Oct 2009
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Jul 2009
The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 4 Jun 2009
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 14 Apr 2009
Endologix Appoints Vice President of Global Marketing
Devices Interventional Personnel
 HSMN NewsFeed - 15 Jan 2009
Peptimmune Grants Major Pharmaceutical Company Exclusive Option to License PI-2301 for Multiple Sclerosis
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2008
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Oct 2008
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 23 Sep 2008
KaloBios Raises $20 Million in Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jul 2008
Peptimmune Announces the Second Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2008
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2008
First Human Implant of New Archus Orthopedics Facet Replacement System
Devices Orthopaedic
 HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
MPM Capital and NEA Lead $65 million Series A Preferred Round to Finance Spinout of TriVascular from Boston Scientific
Devices Interventional Venture Capital
 HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
Biopharmaceuticals Acquisitions Cardiology
 HSMN NewsFeed - 17 Jan 2008
Peptimmune Announces First Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2008
Primera Biosystems Raises $21 Million in Series B Private Round
Diagnostics Venture Capital
 HSMN NewsFeed - 18 Dec 2007
Pacira Pharmaceuticals Names David M. Stack CEO and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 6 Dec 2007
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Sep 2007
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Sep 2007
Third Rock Ventures Debuts with $378 Million Fund in Life Sciences
Venture Capital
 HSMN NewsFeed - 30 Aug 2007
Archus Orthopedics Completes World's First Lumbosacral Facet Joint Replacement
Devices Orthopaedic
 HSMN NewsFeed - 29 Aug 2007
EndoGastric Solutions Raises $30 Million to Fund US Commercialization
Devices Venture Capital
 HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Aug 2007
Archus Orthopedics, Inc. Completes One Hundred TFAS(R) Implants
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur(R), a Novel Extended-Release Opioid Analgesic for Post Operative Pain
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Jun 2007
SkyePharma Inc., Now a Private Pharmaceutical Company, Announces Name Change to Pacira Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 May 2007
Hercules Provides $10 Million Financing to Early-Stage Neosil, a Pharmaceutical Company Developing Dermatological Treatments
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Apr 2007
Xoft, Inc., Announces Additional Funding for Breakthrough Electronic Brachytherapy Technology
Devices Oncology Venture Capital
 HSMN NewsFeed - 3 Apr 2007
Syndax Pharmaceuticals Inc. Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jan 2007
Archus Orthopedics Prevails in Patent Opposition Case
Devices Orthopaedic
 HSMN NewsFeed - 22 Jan 2007
Kenneth M. Bate Named CEO of NitroMed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Cerimon Pharmaceuticals Names Daniel Levitt, M.D., Ph.D. Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2007
Radius Appoints Nick Harvey Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2006
NBI Development Closes $5.5 Million in Seed Round Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 29 Nov 2006
Hercules Provides $15 Million of Financing to Elixir Pharmaceuticals, Inc., a Leading Biopharmaceutical Company
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Elixir Pharmaceuticals Raises $46 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Nov 2006
Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 2 Nov 2006
Cohera Medical, Inc. Announces Dr. Doros Platika Elected as Chairman of the Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 27 Sep 2006
Innovative Spinal Technologies Names Frederic Moll, M.D., to Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 26 Sep 2006
Innovative Spinal Technologies Announces Launch of Paramount(TM) Pedicle Screw System for MIS Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Jul 2006
Nascent Pharmaceuticals Adds Joanna Horobin, M.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2006
Amicus Therapeutics Adds Glenn P. Sblendorio to Board of Directors
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 66

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 66 additional stories matching:
MPM Capital
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!